Goldstein, A.L., Badamchian, M., Thymosins: Chemistry andbiological properties in health and disease (2004) Expert Opin. Biol. Ther., 4, pp. 559-573
Hertzog, M., The beta-thymosin/WH2 domain
structural basis for the switch from inhibition to promotion of actin assembly (2004) Cell, 117, pp. 611-623
Yarmola, E.G., Bubb, M.R., Effects of profilin and thymosin beta4 on the critical concentration of actin demonstrated in vitro and in cell extracts with a novel direct assay (2004) J. Biol. Chem., 279, pp. 33519-33527
Malinda, K.M., Goldstein, A.L., Kleinman, H.K., Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells (1997) FASEB J ., 11, pp. 474-481
Philp, D., Thymosin beta4 promotes matrix metalloproteinase expression during wound repair (2006) J. Cell Physiol., 208, pp. 195-200
Smart, N., Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization (2007) Nature, 445, pp. 177-182
Clark, E.A., Genomic analysis of metastasis reveals an essential role for RhoC (2000) Nature, 406, pp. 532-535
Nummela, P., Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts (2006) Cancer Res., 66, pp. 701-712
Kobayashi, T., Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells (2002) Am. J. Pathol., 160, pp. 869-882
Wang, W.S., Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma (2004) Oncogene, 23, pp. 6666-6671
Wang, W.S., Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells (2003) Oncogene, 22, pp. 3297-3306
Cha, H.J., Jeong, M.J., Kleinman, H.K., Role of thymosin beta4 in tumor metastasis and angiogenesis (2003) J. Natl. Cancer Inst., 95, pp. 1674-1680
Zhang, Y., Thymosin beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation (2008) Cancer Biol. Ther., 7, pp. 419-423
Ji, P., MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in earlystage non-small cell lung cancer (2003) Oncogene, 22, pp. 8031-8041
Grant, D.S., Thymosin beta4 enhances endothelial cell differentiation and angiogenesis (1999) Angiogenesis, 3, pp. 125-135
Smart, N., Rossdeutsch, A., Riley, P.R., Thymosin beta4 and angiogenesis: Modes of action and therapeutic potential (2007) Angiogenesis, 10, pp. 229-241
Caers, J., Multiple myeloma-an update on diagnosis and treatment (2008) Eur. J. Haematol., 81, pp. 329-343
Caers, J., Unraveling the biology of multiple myeloma disease: Cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment (2008) Bull. Cancer, 95, pp. 301-313
Vacca, A., Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma (1999) Blood, 93, pp. 3064-3073
Hose, D., Induction of angiogenesis by normal and malignant plasma cells (2009) Blood, 114, pp. 128-143
Gondo, H., Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes (1987) J. Immunol., 139, pp. 3840-3848
Shimamura, R., Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells (1990) Blood, 76, pp. 977-984
Caers, J., Thymosin {beta}4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma (2009) Haematologica, 95, pp. 163-167
Mahtouk, K., Expression of EGF-family receptors and amphiregulin inmultiple myeloma. Amphiregulin is a growth factor for myeloma cells (2005) Oncogene, 24, pp. 3512-3524
